What Ironwood Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 18 |
| Total trades | 1 | 37 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 42,012 |
| Disposed | 0 | 0 |
| Net activity | +0 | +42,012 |
Common stock only — 35 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Denner Alexander J | Director | Sep 15 | Grant / award · A | +3,694 | — | — | 327,549 |
| Silber Jeffrey | SVP, CMO, Head-Res&Drug | Jul 20 | Grant / award · A | +137,036 | — | — | 137,036 |
| Silver Ronald | PFO & PAO | Jul 07 | Open-market sale · S | −127,890 | $4.52 | −$578K | 313,680 |
| Denner Alexander J | Director | Jun 16 | Grant / award · A | +63,481 | — | — | 323,855 |
| Kessler Marla L | Director | Jun 16 | Grant / award · A | +63,481 | — | — | 229,364 |
| Moukheibir Catherine | Director | Jun 16 | Grant / award · A | +63,481 | — | — | 181,425 |
| Duane Jon R | Director | Jun 16 | Grant / award · A | +63,481 | — | — | 253,820 |
| McHugh Julie | Director | Jun 16 | Open-market sale · S | −21,571 | $3.73 | −$80.5K | 250,749 |
| McHugh Julie | Director | Jun 16 | Grant / award · A | +63,481 | — | — | 272,320 |
| Shepard Jay | Director | Jun 16 | Grant / award · A | +63,481 | — | — | 235,036 |
| Currie Mark G | Director | Jun 16 | Grant / award · A | +63,481 | — | — | 676,900 |
| Denner Alexander J | Director | Jun 15 | Grant / award · A | +4,065 | — | — | 260,374 |
| Silver Ronald | PFO & PAO | May 19 | Grant / award · A | +25,000 | — | — | 441,570 |
| Denner Alexander J | Director | Mar 17 | Open-market sale · S | −5,800 | $3.31 | −$19.2K | 9,188,635 |
| Denner Alexander J | Director | Mar 17 | Open-market sale · S | −6,725,000 | $3.05 | −$20.5M | 9,194,435 |
| Denner Alexander J | Director | Mar 13 | Grant / award · A | +4,451 | — | — | 256,309 |
| Silver Ronald | Principal Accounting Officer | Mar 10 | Grant / award · A | +163,934 | — | — | 416,570 |
| Martini Gregory S. | Chief Financial Officer | Mar 10 | Grant / award · A | +136,612 | — | — | 297,213 |
| Gaskins Tammi L | Chief Commercial Officer | Mar 10 | Grant / award · A | +136,612 | — | — | 350,350 |
| Mccourt Thomas A | Chief Executive Officer | Mar 10 | Grant / award · A | +409,836 | — | — | 1,898,838 |
Loading...
